U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07328113) titled 'Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients' on Nov. 25, 2025.
Brief Summary: Chronic kidney disease (CKD) is often associated with multiorgan complications, including thyroid hormone dysfunction. Interleukin-6 (IL-6), a pro-inflammatory cytokine, has been proposed as a marker of inflammation that may contribute to these alterations. The main question it aims to answer is:
Is there an association between interleukin-6 and thyroid hormone dysfunction in patients with chronic kidney disease (CKD) Blood samples will be collected and analyzed from 65 patients who have undergone hemodialysis for at least 3 months.
Stu...